Arrowgrass Capital Partners (US)’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-147,568
Closed -$2.24M 341
2015
Q1
$2.24M Buy
+147,568
New +$2.24M 0.03% 136